Serological responses to SARS-CoV-2 following non-hospitalised infection: clinical and ethnodemographic features associated with the magnitude of the antibody response
Open Access
- 23 September 2021
- journal article
- research article
- Published by BMJ in BMJ Open Respiratory Research
- Vol. 8 (1), e000872
- https://doi.org/10.1136/bmjresp-2020-000872
Abstract
Objective To determine clinical and ethnodemographic correlates of serological responses against the SARS-CoV-2 spike glycoprotein following mild-to-moderate COVID-19. Design A retrospective cohort study of healthcare workers who had self-isolated due to COVID-19. Setting University Hospitals Birmingham NHS Foundation Trust, UK (UHBFT). Participants 956 healthcare workers were recruited by open invitation via UHBFT trust email and social media between 27 April 2020 and the 8 June 2020. Intervention Participants volunteered a venous blood sample that was tested for the presence of anti-SARS-CoV-2 spike glycoprotein antibodies. Results were interpreted in the context of the symptoms of their original illness and ethnodemographic variables. Results Using an assay that simultaneously measures the combined IgG, IgA and IgM response against the spike glycoprotein (IgGAM), the overall seroprevalence within this cohort was 46.2% (n=442/956). The seroprevalence of immunoglobulin isotypes was 36.3%, 18.7% and 8.1% for IgG, IgA and IgM, respectively. IgGAM identified serological responses in 40.6% (n=52/128) of symptomatic individuals who reported a negative SARS-CoV-2 PCR test. Increasing age, non-white ethnicity and obesity were independently associated with greater IgG antibody response against the spike glycoprotein. Self-reported fever and fatigue were associated with greater IgG and IgA responses against the spike glycoprotein. The combination of fever and/or cough and/or anosmia had a positive predictive value of 92.3% for seropositivity in self-isolating individuals a time when Wuhan strain SARS-CoV-2 was predominant. Conclusions and relevance Assays employing combined antibody detection demonstrate enhanced seroepidemiological sensitivity and can detect prior viral exposure even when PCR swabs have been negative. We demonstrate an association between known ethnodemographic risk factors associated with mortality from COVID-19 and the magnitude of serological responses in mild-to-moderate disease.Funding Information
- Medical Research Council (MC_PC_17183)
- International AIDS Vaccine Initiative (INV-008352/OPP1153692, OPP1196345/INV-008813)
- National Institute for Health Research (BRC-1215-20009)
- Scripps Consortium for HIV Vaccine Development (AI144462)
- UK Research and Innovation
This publication has 37 references indexed in Scilit:
- Immunosenescence and human vaccine immune responsesImmunity & Ageing, 2019
- Loss of the interleukin-6 receptor causes immunodeficiency, atopy, and abnormal inflammatory responsesThe Journal of Experimental Medicine, 2019
- Can physical activity ameliorate immunosenescence and thereby reduce age-related multi-morbidity?Nature Reviews Immunology, 2019
- Poor Correlation between Pneumococcal IgG and IgM Titers and Opsonophagocytic Activity in Vaccinated Patients with Multiple Myeloma and Waldenstrom's MacroglobulinemiaClinical and Vaccine Immunology, 2016
- A defunctioning polymorphism in FCGR2B is associated with protection against malaria but susceptibility to systemic lupus erythematosusProceedings of the National Academy of Sciences of the United States of America, 2010
- The induction of antibody production by IL-6 is indirectly mediated by IL-21 produced by CD4+ T cellsThe Journal of Experimental Medicine, 2009
- Elevated C-Reactive Protein Levels in Overweight and Obese AdultsJAMA, 1999
- Reduction in Functional Antibody Activity Against Streptococcus pneumoniae in Vaccinated Elderly Individuals Highly Correlates with Decreased IgG Antibody AvidityClinical Infectious Diseases, 1999
- Subcutaneous Adipose Tissue Releases Interleukin-6, But Not Tumor Necrosis Factor-α,in Vivo1Journal of Clinical Endocrinology & Metabolism, 1997
- Subcutaneous Adipose Tissue Releases Interleukin-6, But Not Tumor Necrosis Factor- , in VivoJournal of Clinical Endocrinology & Metabolism, 1997